Sejong Medical said it has been suspended from manufacturing its disposable guide needles for three months by the Ministry of Food and Drug Safety after failing to obtain authorization after a change in the device's approval status. The administrative action will be enforced from Thursday to Dec. 27
Bridge Biotherapeutics announced on Tuesday that it will discontinue the development of BBT-176, a drug candidate for non-small cell lung cancer (NSCLC), and BBT-212, another candidate for fundus disease.Instead, the company stated it would focus on BBT-877 and BBT-207, candidates for idiopathic pul
The Korean government decided to keep the health insurance premiums unchanged at 7.09 percent for 2024 due to high inflation and interest rates. The Ministry of Health and Welfare announced that it convened a meeting of the health insurance policy deliberation committee on Tuesday afternoon and dete
Severance Hospital said on Tuesday that it successfully transplanted cell therapy products derived from embryonic stem cells into the brain of a patient to treat Parkinson's disease.The investigational drug is a midbrain dopamine neural progenitor cells differentiated from human embryonic stem cells
In response to the spread of the Covid-19 variants, the government will start vaccinating citizens free of charge with the new vaccine targeting the prevalent XBB variant, specifically XBB.1.5, from Oct. 19, 2023 to March 31, 2024.The Korea Disease Control and Prevention Agency (KDCA) said that it w
With a dream to revolutionize the field of diagnostics, Eone Diagnomics Genome Center (EDGC) is charting a way forward to use methylation patterns as a way to encourage early disease detection, starting with cancer and hoping to expand to neurodegenerative diseases such as Alzheimer's disease and in
Researchers at the Institute of Basic Science (IBS) have identified a neural circuit in the brain linked to social impairments caused by autism spectrum disorder (ASD).ASD is characterized by reduced sociability and repetitive behaviors, affecting approximately 2.8 percent of the global population.D
The government is expanding its investigation into medical centers that falsely bill for Covid-19 treatment to the entire nation. The investigation will cover 8,423 medical institutions nationwide, from tertiary general hospitals to neighborhood clinics that treat Covid-19 patients.The National Heal
Celltrion said it has received marketing approval from the Japanese Ministry of Health, Labor, and Welfare for Yuflyma, a biosimilar referencing Humira (ingredient: adalimumab).Humira, the original medicine, is prescribed primarily for autoimmune diseases such as rheumatoid arthritis, inflammatory b
Daewon Pharmaceutical said Monday the company has signed a contract with PT Interbat, an Indonesian pharmaceutical company, for the exclusive export and supply of finished products of non-steroidal anti-inflammatory drugs (NSAIDs), Pelubi SR Tab (pelubiprofen).The contract's total value is $3 millio
AbClon said Monday the company would expand its phase 2 clinical trial for its chimeric antigen receptor T-cell (CAR-T) therapy candidate, AT101. to seven sites.In addition to Asan Medical Center, Ajou University Hospital, Ulsan National University Hospital, and Dong-A University Hospital, where the
Dongkook Pharmaceutical is drawing the industry’s attention by completing the phase 3 clinical trial of its new therapy for benign prostatic hyperplasia (BPH), which combines dutasteride and tadalafil.Dongkook Pharm said Monday that it has confirmed the efficacy and safety of DKF-313, an improved co
Janssen, which will launch the first generic version of prostate cancer treatment Zytiga (abiraterone acetate) with insurance benefit, has introduced Akeega, a prostate cancer therapy combining the existing abiraterone and PARP inhibitor niraparib, in Korea.On Monday, the Ministry of Food and Drug S
Philips Korea said on Tuesday that it installed its digital pathology solution at Konyang University Hospital, making the hospital the first university hospital in the central part of Korea equipped with a full digital pathology system.Philips IntelliSite Pathology Solution is a digital pathology im
Novo Nordisk Korea said it showcased its innovative Mallya Smart Sensor technology, a diabetes management solution, at the Korea Digital Future Innovation Exhibition 2023, being held at COEX, Seoul, from Monday to Wednesday this week.The Denmark-based company's new smart sensor promises to revolutio
The latest results of a new treatment for epithelial growth factor receptor (EGFR)-mutant lung cancer that has acquired resistance to current targeted therapies are drawing attention.On Monday, a research team led by Dr. Cho Byoung-chul Cho, a professor at Yonsei University Lung Cancer Center, annou
Last year, 1,066 people were infected with HIV/AIDS, a 9.3 percent increase from the previous year. Five people were infected through the shared use of narcotics.Rep. Choi Young-hee of the People Power Party analyzed data on the status of AIDS infection in the last five years submitted by the Korea
Pinotbio, a local biotech specializing in antibody-drug conjugates (ADC), said it has been selected for a major ADC development project sponsored by the Korea Drug Development Fund (KDDF).The initiative, named the "Global Blockbuster ADC Anticancer Drug Component Development Project," aims to suppor
EyeGene said on Friday in a public filing that its phase 2 clinical trial of EG-Myocin, a drug candidate for the treatment of myocardial ischemia and reperfusion injury, failed to show statistically significant changes in myocardial infarction size. The study explored the effectiveness and safety of
Starting in October, the reimbursement standards for the spinal muscular atrophy (SMA) drugs Spinraza (nusinersen) and Evrysdi (risdiplam) will be expanded and newly established.The Ministry of Health and Welfare (MOHW) issued an administrative notice on the “Partial amendment to the details (pharma